In the first Vasodilator Heart Failure Trial (V-HeFT), the combination of the antioxidant hydralazine with isosorbide dinitrate—which stimulates nitric oxide signaling—was beneficial in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback